Font:
ME

MEDICAMEQ / NSE / Biotechnology & Drugs

Medicamen Biotech

INR 247.417.85 (-5.09%) 1D
Last updated: 2026-06-16T06:38:35.623361+00:00
Price Chart

1Y Price Trend

Open415.75
High447.65
Low216.95
Close225.25
Volume42,044
Change-190.5
Change %-45.82%

Key Information

Ticker SymbolMEDICAMEQ
Current Price247.4
52-Week High447.65
52-Week Low216.95
Market Cap331.64
Beta1.2
Volume42,044
ISININE646B01010
Day High239.4
Day Low224
Open233.9

Recommendations

Target High454

Target Low220

Target Mean0

Target Median0

Risk Metrics

Overall RiskHigh risk

Board Risk46.4

Key Analysis

Overall score, performance score, return rating, defensive, aggressive, and balanced views.

Download app

Projection Analytics

Best-case, base-case, worst-case, and dynamic AI projection views.

Download app
News

Latest stock news

Medicamen Biotech Ltd is Rated Strong Sell - Markets Mojo17 days ago
Market news

Medicamen Biotech Ltd is Rated Strong Sell Markets Mojo

Medicamen Biotech Ltd Reports Strong Quarterly Turnaround Amid Long-Term Challenges - Markets Mojo20 days ago
Market news

Medicamen Biotech Ltd Reports Strong Quarterly Turnaround Amid Long-Term Challenges Markets Mojo

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges - Markets Mojo22 days ago
Market news

Medicamen Biotech Ltd Valuation Shifts Signal Renewed Price Attractiveness Amid Sector Challenges Markets Mojo

Medicamen Biotech Ltd is Rated Sell - Markets Mojo22 days ago
Market news

Medicamen Biotech Ltd is Rated Sell Markets Mojo

Medicamen Biotech Q4 FY26: Strong Quarter Masks Deeper Structural Concerns - Markets Mojo22 days ago
Market news

Medicamen Biotech Q4 FY26: Strong Quarter Masks Deeper Structural Concerns Markets Mojo

Medicamen Biotech FY26 net profit rises to ₹979.64 lakh - scanx.trade22 days ago
Market news

Medicamen Biotech FY26 net profit rises to ₹979.64 lakh scanx.trade

Medicamen Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 - marketscreener.com22 days ago
Market news

Medicamen Biotech Limited Recommends Final Dividend for the Financial Year Ended March 31, 2026 marketscreener.com

Medicamen Bio Standalone March 2026 Net Sales at Rs 54.68 crore, up 110.35% Y-o-Y - Moneycontrol.com22 days ago
Market news

Medicamen Bio Standalone March 2026 Net Sales at Rs 54.68 crore, up 110.35% Y-o-Y Moneycontrol.com

FAQ

Stock FAQs

What is the NSE symbol for Medicamen Biotech?

Medicamen Biotech trades on NSE with the symbol MEDICAMEQ. ShareKeyX uses the stock symbol in the public URL and keeps ISIN only for internal data matching and structured data.

Where can I track Medicamen Biotech share price and chart?

You can track Medicamen Biotech share price, OHLC chart, key information, ratios, financials, company information and news on this ShareKeyX market page.

Does ShareKeyX show financial data for Medicamen Biotech?

Yes. ShareKeyX displays available financial statements for Medicamen Biotech using the current Supabase company financial payload. Statement values are shown in INR crore.

Does ShareKeyX show historical OHLC data for Medicamen Biotech?

Yes. ShareKeyX displays available historical OHLC candles for Medicamen Biotech across supported chart ranges such as 7D, 1M, 3M, 6M and 1Y.

What sector or industry does Medicamen Biotech belong to?

Medicamen Biotech is classified under Biotechnology & Drugs in the available company data.

Does ShareKeyX show news for Medicamen Biotech?

Yes. ShareKeyX shows the latest available stock news for Medicamen Biotech from the connected stock news source.